Literature DB >> 23708680

Role of Education in HIV Clinical Outcomes in a Tuberculosis Endemic Setting.

Gabriel M Cohen1, Lise Werner2, Santhanalakshmi Gengiah2, Kogieleum Naidoo2.   

Abstract

This study evaluated how educational attainment impacts clinical outcomes of HIV-positive patients in Durban, South Africa. The authors conducted a prospective study of 466 adult HIV-positive patients initiating antiretroviral therapy (ART) at an urban TB-HIV clinic from October 2004 to June 2007. The level of educational attainment (highest grade completed) was assessed at ART initiation. The authors measured tuberculosis treatment outcomes as well as death, lost to follow-up, viral suppression (HIV RNA <400 copies/mL), and immunologic response (CD4 ≥200 cells/mm(3)) at 6, 12, and 24 months after ART initiation. After 24 months of ART initiation, there were 43 deaths; viral suppression and immunologic response were observed in 88% and 83% of the remaining patients, respectively. The authors found no association between level of educational attainment and mortality (P = .12), loss to follow-up (P = .85), virologic response (P = .51), or immunologic response (P = .63). Similar findings were observed at 6 and 12 months post-ART initiation.
© The Author(s) 2013.

Entities:  

Keywords:  HIV infection; education; mortality; southern Africa; tuberculosis

Mesh:

Year:  2013        PMID: 23708680      PMCID: PMC3888482          DOI: 10.1177/2325957413488185

Source DB:  PubMed          Journal:  J Int Assoc Provid AIDS Care        ISSN: 2325-9574


  29 in total

1.  Social health inequalities during the course of chronic HIV disease in the era of highly active antiretroviral therapy.

Authors:  Rosemary Dray-Spira; France Lert
Journal:  AIDS       Date:  2003-02-14       Impact factor: 4.177

2.  Drug resistance and adherence to HIV/AIDS antiretroviral treatment: against a double standard between the north and the south.

Authors:  Jean Paul Moatti; Bruno Spire; Michel Kazatchkine
Journal:  AIDS       Date:  2004-06       Impact factor: 4.177

Review 3.  Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.

Authors:  Edward J Mills; Jean B Nachega; Iain Buchan; James Orbinski; Amir Attaran; Sonal Singh; Beth Rachlis; Ping Wu; Curtis Cooper; Lehana Thabane; Kumanan Wilson; Gordon H Guyatt; David R Bangsberg
Journal:  JAMA       Date:  2006-08-09       Impact factor: 56.272

Review 4.  Tuberculosis treatment outcomes in Europe: a systematic review.

Authors:  A Faustini; A J Hall; C A Perucci
Journal:  Eur Respir J       Date:  2005-09       Impact factor: 16.671

5.  AIDS mortality before and after the introduction of highly active antiretroviral therapy: does it vary with socioeconomic group in a country with a National Health System?

Authors:  Carme Borrell; Maica Rodríguez-Sanz; M Isabel Pasarín; M Teresa Brugal; Patricia García-de-Olalla; Marc Marí-Dell'Olmo; Joan Caylà
Journal:  Eur J Public Health       Date:  2006-05-12       Impact factor: 3.367

6.  Trends and characteristics of AIDS mortality in the Rio de Janeiro city after the introduction of highly active antiretroviral therapy.

Authors:  Valéria Saraceni; Marly Marques da Cruz; Lilian de Mello Lauria; Betina Durovni
Journal:  Braz J Infect Dis       Date:  2005-10-03       Impact factor: 1.949

7.  Rate, pattern and barriers of HIV serostatus disclosure in a resource-limited setting in the Niger delta of Nigeria.

Authors:  C I Akani; O Erhabor
Journal:  Trop Doct       Date:  2006-04       Impact factor: 0.731

8.  TB treatment outcomes following directly-observed treatment at an urban outpatient specialist TB facility in South Africa.

Authors:  A B M Kharsany; C Connolly; A Olowolagba; S S Abdool Karim; Q Abdool Karim
Journal:  Trop Doct       Date:  2006-01       Impact factor: 0.731

9.  Traditional beliefs about the cause of AIDS and AIDS-related stigma in South Africa.

Authors:  S C Kalichman; L Simbayi
Journal:  AIDS Care       Date:  2004-07

10.  Baseline predictors of CD4 T-lymphocyte recovery with combination antiretroviral therapy.

Authors:  Kara K Bennett; Victor G DeGruttola; Ian C Marschner; Diane V Havlir; Douglas D Richman
Journal:  J Acquir Immune Defic Syndr       Date:  2002-09-01       Impact factor: 3.731

View more
  4 in total

1.  Predictors for Poor Linkage to Care Among Hospitalized Persons Living with HIV and Co-Occurring Substance Use Disorder.

Authors:  Nathan A Summers; Jonathan A Colasanti; Daniel J Feaster; Wendy S Armstrong; Allan Rodriguez; Mamta K Jain; Petra Jacobs; Lisa R Metsch; Carlos Del Rio
Journal:  AIDS Res Hum Retroviruses       Date:  2020-03-03       Impact factor: 2.205

Review 2.  Virological success after 12 and 24 months of antiretroviral therapy in sub-Saharan Africa: Comparing results of trials, cohorts and cross-sectional studies using a systematic review and meta-analysis.

Authors:  Fabien Taieb; Yoann Madec; Amandine Cournil; Eric Delaporte
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

3.  Diagnostic Errors in Tuberculous Patients: A Multicenter Study from a Developing Country.

Authors:  Hashem Neshati; Fereshte Sheybani; HamidReza Naderi; MohamadReza Sarvghad; Ahmad Khalifeh Soltani; Elaheh Efterkharpoor; Mehdi Jabbari Nooghabi
Journal:  J Environ Public Health       Date:  2018-11-13

Review 4.  The HIV care cascade in sub-Saharan Africa: systematic review of published criteria and definitions.

Authors:  Catrina Mugglin; Delia Kläger; Aysel Gueler; Fiona Vanobberghen; Brian Rice; Matthias Egger
Journal:  J Int AIDS Soc       Date:  2021-07       Impact factor: 5.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.